Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jee Sun

Jee Sun Lee, Seoul KR

Patent application numberDescriptionPublished
20090155412Enzymatic Interesterification Using Stepwise Changes In Temperature For Development of Trans Fat-Free Fats and Oils - Disclosed herein is a method of preparing trans fat-free oils and fats by an enzymatic interesterification (EI), and trans fat-free oils and fats prepared by the method. Specifically, the method comprises the steps of: 1) mixing fully hydrogenated fat derived from vegetable oil with RBD olive oil; 2) adding lipase to the mixed oil and reacting the mixed oil with lipase at 65 to 80° C. for 1 to 4 hours (106-18-2009

Jee Sun Shin, Seoul KR

Patent application numberDescriptionPublished
20090050524METHOD FOR PRODUCING FEEDSTOCKS OF HIGH QUALITY LUBE BASE OIL FROM UNCONVERTED OIL - The present invention relates to a method of producing a feedstock for high-quality lube base oil from unconverted oil (UCO) obtained from fuel oil hydrocracking, and more particularly to a method of producing a feedstock for high-quality lube base oil by treating vacuum gas oil (VGO) or a mixture of vacuum gas oil (VGO) with coker gas oil (CGO) or deasphalted oil (NAO) as a feedstock in a hydrotreating unit and a first hydrocracking unit and recycling the resulting unconverted oil (UCO) through a second hydrocracking unit.02-26-2009
20100193400METHOD FOR PRODUCING FEEDSTOCKS OF HIGH QUALITY LUBE BASE OIL FROM COKING GAS OIL - Disclosed herein is a method of producing feedstock of high-quality lube based oil by producing coker gas oil (CGO) from vacuum residue (VR) or a mixture (VR/AR) of atmospheric residue (AR) and vacuum residue (VR), performing a hydrotreating process and a hydrocracking process by mixing the coker gas oil (CGO) with vacuum gas oil (VGO) to form unconverted oil (UCO), and then recycling the unconverted oil. The method of producing feedstock of high-quality lube based oil is advantageous in that feedstock of high-quality lube based oil can be more economically and efficiently produced using cheap coker gas oil (CGO), which is hard to treat.08-05-2010
20110005972PROCESS FOR MANUFACTURING NAPHTHENIC BASE OILS FROM EFFLUENCES OF FLUIDIZED CATALYTIC CRACKING UNIT - Disclosed is a method of manufacturing high-quality naphthenic base oil by subjecting, as a feedstock, light cycle oil (LCO) and slurry oil (SLO) obtained through fluidized catalytic cracking (FCC) to hydrotreating and dewaxing.01-13-2011
20110089080PROCESS FOR MANUFACTURING HIGH QUALITY NAPHTHENIC BASE OILS - A method of manufacturing high-quality naphthenic base oils comprising a high aromatic content and a large amount of impurities with a boiling point higher than that of gasoline. High-quality naphthenic base oil may be manufactured from light cycle oil (LCO) and slurry oil (SLO), which are inexpensive, and have a high aromatic content, a large amount of impurities, and which are effluents of a fluidized catalytic cracking (FCC) unit. The method also relates to the pretreatment process of a feedstock, where the amounts of impurities (sulfur, nitrogen, polynuclear aromatic compounds and various metals components) in the feedstock are reduced.04-21-2011

Patent applications by Jee Sun Shin, Seoul KR

Jee Sun Yang, Seoul KR

Patent application numberDescriptionPublished
20100144708HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER - The present invention relates to new heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and a pharmaceutical composition comprising the same for treatment of cancer. The compounds according to the present invention induce DNA damage due to reactive oxygen species to activate c-abl and p53, induce RhoB to generate apoptosis, and induce cell death by down-regulating Bcl2 involved in cell survival, which is generated by dysregulated signals via the mitochondria pathway, thereby inhibiting tumor cell growth and inducing apoptosis. Accordingly, the composition according to the present invention can be used to treat cancer.06-10-2010